Navigation Links
Covance Reports Fourth Quarter Revenue of $492 Million, GAAP EPS of $0.45, and Pro Forma EPS of $0.56
Date:1/26/2011

(2)Pro FormaNet revenues$ 1,867,634$ 1,867,634Reimbursable out-of-pocket expenses94,99294,992Total revenues1,962,626--1,962,626Costs and expenses:  Cost of revenue1,277,1421,277,142  Reimbursable out-of-pocket expenses94,99294,992  Selling, general and administrative270,593270,593  Depreciation and amortization91,28991,289  Asset impairment charges--Total costs and expenses1,734,016--1,734,016Income from operations228,610--228,610Other expense (income), net:  Interest expense (income), net201201  Foreign exchange transaction loss, net245245  Gain on sale of businesses(9,681)9,681-Other expense (income), net(9,235)-9,681446Income before taxes and equity investee earnings237,845-(9,681)228,164Tax expense62,8702,072(3,388)61,554Equity investee earnings907907Net income $
75,882$
(2,072)$
(6,293)$
7,517Basic earnings per share$
2.76$
(0.03)$
(0.10)$
2.62Weighted average shares outstanding - basic63,818,71763,818,71763,818,71763,818,717Diluted earnings per share$
2.73$
(0.03)$
(0.10)$
2.60Weighted average shares outstanding - diluted64,341,08464,341,08464,341,08464,341,084(1) Represents favorable resolutions of income tax matters during the year ended December 31, 2009.(2) Includes a $9,026 gain on sale of Interactive Voice & Web Response Services ($5,867 net of tax) and a $655 gain on sale of Cardiac Safety Services ($426 net of tax).
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
2. Covance Receives Highest Level of Phase I Accreditation
3. Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call
4. Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference
5. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
6. Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc.
7. Covance to Present at Piper Jaffray 21st Annual Health Care Conference
8. Covance To Present At The 20th Annual Global Healthcare Services Conference
9. Covance To Present at the Deutsche Bank 35th Annual Health Care Conference
10. Covance to Present at Goldman Sachs 31st Annual Global Healthcare Conference
11. Covance to Present at William Blair & Companys 30th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... February 26, 2015 ABIVAX, a clinical ... vaccines, today announced that it has dosed in ... IIb/III clinical trial of ABX203 which is taking place in ... The study is designed to assess whether ABX203 can deliver ... (CHB) via controlling viral load for a much longer period ...
(Date:2/26/2015)... 2015   HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... million for the fourth quarter ended December 31, 2014, ... for the same period of 2013.  For the fiscal ... a 34% increase compared to revenue of $207.9 million ...
(Date:2/26/2015)... 26, 2015  Caris Life Sciences® today announced ... Genitourinary Cancers Symposium in Orlando, Fla. ... the Audio Poster Tour. Both studies utilized Caris ... service. These studies showed that panomic testing can ... carcinomas (RCC), providing insights that may drive selection ...
Breaking Medicine Technology:ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 2ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 3ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 4ABIVAX Recruits First Patient in a Pivotal Phase IIb/III Clinical Trial with ABX203, a Novel Immunotherapy Against Chronic Hepatitis B 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 2HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 3HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 4HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 5HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 6HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 7HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 8HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 9HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 10HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 11HeartWare International Reports $73.2 Million In Fourth Quarter 2014 Revenue; 38% Increase From Fourth Quarter 2013 12Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 2Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 3Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 4Caris Life Sciences' Multiplatform Tumor Profiling Helps to Identify Potential Predictive Biomarkers in Renal Cell Carcinoma 5
... DATA ), a technology and services company focused ... reported its,operating results for the first quarter of 2008., ... revenue decreased,approximately 41% to $2,088,000 and the Company reported ... both a basic and diluted basis. These,results compared with ...
... data support potential of asenapine in the treatment of ... schizophrenia and bipolar I ... ) today announced that an overview of asenapine clinical trials,from ... of the,American Psychiatric Association in Washington, D.C., May 3-8. Data ...
Cached Medicine Technology:DATATRAK International Reports First Quarter Results for 2008 2DATATRAK International Reports First Quarter Results for 2008 3DATATRAK International Reports First Quarter Results for 2008 4DATATRAK International Reports First Quarter Results for 2008 5DATATRAK International Reports First Quarter Results for 2008 6DATATRAK International Reports First Quarter Results for 2008 7Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
(Date:2/26/2015)... San Francisco, CA (PRWEB) February 26, 2015 ... at the American College of Traditional Chinese Medicine (ACTCM). ... March, starting off with the Chinese New Year celebration ... The event schedule is as follows: , Sunday, March ... – 2:30 p.m., ACTCM celebrates the Chinese New Year ...
(Date:2/26/2015)... 2015 β€œIn the last few years, ... evolution of one of the newest hair restoration technologies ... offers a machinery that facilitates the extraction of ... scalp,” said Dr. Parsa Mohebi. , Although ARTAS had ... at which the device extracted these grafts could not ...
(Date:2/26/2015)... Thousands of people in local communities nationwide ... for the Muscular Dystrophy Association during the 2015 MDA ... that will help save and improve the lives of ... Walk events unite and rally communities to raise funds ... are compromised β€” including everyday abilities like walking, running, ...
(Date:2/26/2015)... The COR HEALTH division of Vets Access, LLC, ... offer customers a full line of Topricin® pain relief ... effectively address muscle, joint, and nerve pain. COR ... Montrose, MI, that is dedicated to providing natural, safe ... a research and development leader in topical natural biomedicines ...
(Date:2/26/2015)... February 26, 2015 A Beautiful Smile ... practice is offering the following 50 year celebration specials ... their choice of Sonic Care Diamond Clean or the ... respectively). The cost is $2895 for the Invisalign ... more than ten treatment procedures are priced accordingly). ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces March Schedule of Events 2Health News:Newest Technology now Available at Parsa Mohebi Hair Restoration 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 2Health News:MDA Kicks-Off Annual Muscle Walk Season in Local Communities Nationwide to Fight Back Against Muscle Disease 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3
... of its kind, 161 postnatal women with no previous ... test the effect of a physiotherapist-led exercise and education ... an eight-week "Mother and Baby" program, including specialized exercises ... education. In the second group, "Education Only" ...
... University of Delaware have developed a new method for ... other diseases., Developed by Zhihao Zhuang, UD assistant professor ... chemical method yields hundredsfold more ubiquitylated proteins than current ... such mysteries as how cancer cells gain resistance to ...
... ... new web based clinical Label Approval System - LAS a unique workflow-based label approval ... ... the launch of their new web based clinical Label Approval System - LAS a ...
... , This release is available in ... Traditional Chinese acupuncture (TCA), where very thin ... the body to elicit beneficial therapeutic responses, may ... suffer from persistent post- viral olfactory dysfunction (PVOD), ...
... of poverty and unemployment rates that are nearly double ... Oregon tend to make less use of public assistance, ... University,s Family Policy Program. OSU researchers Deana Grobe ... University of Minnesota, found that the rates of use ...
... Mich. More than one in four elderly Americans lacked the ... of life, according to a study of 3,746 people to be ... . Those who had advance directives - including living wills ... they wanted most of the time, says lead author Maria Silveira, ...
Cached Medicine News:Health News:New mums beat the blues and increase wellbeing with physio exercise, study reveals 2Health News:UD team develops new method for producing proteins critical to medical research 2Health News:Almac to Improve Label Approval Process in Clinical Trials 2Health News:Almac to Improve Label Approval Process in Clinical Trials 3Health News:Acupuncture may be an effective treatment for post-viral infection loss of smell 2Health News:Despite much-higher poverty rates, rural Oregonians use less public assistance 2Health News:Despite much-higher poverty rates, rural Oregonians use less public assistance 3Health News:More than one-quarter of elderly patients lack decision-making capacity at death 2Health News:More than one-quarter of elderly patients lack decision-making capacity at death 3
Self retaining brain retractor....
The Budde Halo brain retractor is designed for use in all intercranial procedures where retraction of delicate brain tissue is required....
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm)....
Cushing periosteal elevators, Gutsch handle, sharp, narrow, blade width 3/16" (5 mm), length 7 5/8" (194 mm)....
Medicine Products: